The primary value of placebo controls in clinical trials is the minimization of bias.

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...

Catarina Craveiro, a biomedical research ... example, recalls one of the first cases he consulted on decades ago when a physician sought his advice about giving low-dose aspirin — essentially a ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

In clinical trials, a comparator drug (defined as ‘an investigational or marketed product [i.e. active control] or placebo used as ... are considered. Examples include a Cox-2 selective ...

Now, an extension of the work is starting that will see if AI can be used to reduce or remove the need for a control group in some clinical trials, for example ... assigned to placebo or standard ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

The Phase 2b ICONA clinical trial was a 52-week randomized, double-blind, placebo-controlled trial that evaluated the safety and histological impact of icosabutate at 300 and 600 mg compared to ...